RecruitingNot ApplicableNCT06066918
Prophylactic Pregabalin Treatment Following Spinal Cord Injury
The Effect of Preventional Drug Therapy on Pain Regulation Mechanisms Among Spinal Cord Injury Patients Who Have Yet to Develop Central Pain
Sponsor
Loewenstein Hospital
Enrollment
50 participants
Start Date
Jul 13, 2021
Study Type
INTERVENTIONAL
Conditions
Summary
Patients arriving to rehabilitation up to 3 months following SCI will be given (study group) or not (control group) Lyrica (75X2). They will be followed for central pain development.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Up to 3 months following traumatic or non-traumatic SCL
- Ability to give informed consent and cooperate
Exclusion Criteria6
- Pregnancy
- Neurological or other medical conditions that may interfere with sensation
- Neuropathic-like pain before recruitment (described as painful sensation of electric current, burning, numbness, tingling, pricking, or squeezing)
- Being treated with Pregabalin
- Blood creatinine levels >1.2 or creatinine clearance <60
- Sensitivity to lactose
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGPregabalin 75mg
Pregabalin 75 mg twice a day
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06066918
Related Trials
Deciphering Preserved Autonomic Function After Spinal Cord Injury
NCT044933721 location
Pain Phenotyping in Patients With Neuropathic Pain After Spinal Cord Injury
NCT064432811 location
ARC-IM System to Manage Symptomatic Blood Pressure Instability Secondary to Chronic Spinal Cord Injury
NCT0714729612 locations
Nomad P-KAFO Study
NCT056445221 location
Improving Adherence to Spinal Cord Injury Exercise Guidelines Using Smartphone Technology and E-coaching
NCT054241721 location